Add Yahoo as a preferred source to see more of our stories on Google. Medtronic has launched the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and ...

US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to initiate a clinical study of its ...

Medtronic today announced that the first U.S. commercial surgical case using its recently FDA-cleared Hugo™ robotic-assisted surgery (RAS) system has been successfully performed by Jihad Kaouk, MD, ...

The two other U.S. IDE clinical studies — Expand URO and Enable Hernia Repair — both met their primary safety and effectiveness endpoints. Also, in July, positive results from a Medtronic-sponsored ...

EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals in early 2025 Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and ...

Medtronic announced the first U.S. commercial cases for its Hugo soft-tissue robotic surgery system, conducted at Cleveland Clinic.

To read the full story, subscribe or sign in. MMI gets IDE for robotic microsurgical study in Alzheimer’s Nov. 10, 2025 By Holland Johnson ...

Company prepares to support clinical trial in the United States NEW BRUNSWICK, N.J., Nov. 12, 2024 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery ...

JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...

First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY ...